178 related articles for article (PubMed ID: 3855943)
1. Ca-125 levels in the conditioned media of the gynecological tumor cell lines.
Ishiwata I; Ishiwata C
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jan; 37(1):147-8. PubMed ID: 3855943
[No Abstract] [Full Text] [Related]
2. [Serum CA 125 and TPA determination in malignant neoplasms of the uterus].
Gadducci A; Facchini V; Bartolini T; Fioretti P
Ann Ostet Ginecol Med Perinat; 1988; 109(3):151-5. PubMed ID: 3207319
[No Abstract] [Full Text] [Related]
3. [Importance of CA-50 detection in malignant gynecologic tumors].
Indraccolo SR; Greco A; Cartechini MG; Compagnucci P
Minerva Ginecol; 1990 Dec; 42(12):507-9. PubMed ID: 2089292
[TBL] [Abstract][Full Text] [Related]
4. [Detection of CA-125 antigen (non-mucinous ovarian cancer antigen)-- in serum of patients with gynecological malignancies].
Sakamoto S; Kawana H; Shimizu K; Ishihara T; Ueda K; Usman SM; Uchida S; Kawagoe K; Kihara K; Kubo H
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Aug; 36(8):1261-2. PubMed ID: 6595322
[No Abstract] [Full Text] [Related]
5. A review of tumor antigens in gynecologic malignancies.
Gall SA
J Reprod Med; 1975 Jan; 14(1):12-6. PubMed ID: 162963
[TBL] [Abstract][Full Text] [Related]
6. An immunologic comparison between serous cystadenocarcinoma of the ovary and other human gynecologic tumors.
Bhattacharya M; Barlow JJ
Am J Obstet Gynecol; 1973 Nov; 117(6):849-53. PubMed ID: 4126800
[No Abstract] [Full Text] [Related]
7. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas.
Sonoda K; Nakashima M; Kaku T; Kamura T; Nakano H; Watanabe T
Cancer; 1996 Apr; 77(8):1501-9. PubMed ID: 8608535
[TBL] [Abstract][Full Text] [Related]
8. [Distribution of oncotrophoblast antigens defined by monoclonal antibodies].
Inoue R
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1837-43. PubMed ID: 3209911
[TBL] [Abstract][Full Text] [Related]
9. Immunological aspects of gynecological malignancies.
DiSaia PJ
J Reprod Med; 1975 Jan; 14(1):17-20. PubMed ID: 1110478
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of CA 19-9 as a tumor marker for gynecologic malignancies].
Inoue M; Saitoh J; Abe Y; Inoue Y; Ueda G; Tanizawa O; Gamoh Y; Dan A; Satoh T
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2411-4. PubMed ID: 3865972
[No Abstract] [Full Text] [Related]
11. Lymphocyte function and HL-A antigen frequency in gynecologic squamous cancer. A preliminary report.
Twomey PL; Rogentine GN; Chretien PB
Int Surg; 1974 Sep; 59(9):468-72. PubMed ID: 4414534
[No Abstract] [Full Text] [Related]
12. Carcinoembryonic antigen in cancer of the female reproductive system: its detection in serum by a microradioimmunoassay.
Khoo SK; Mackay EV
Aust N Z J Obstet Gynaecol; 1973 May; 13(2):107-13. PubMed ID: 4518714
[No Abstract] [Full Text] [Related]
13. [Tissue polypeptide antigen in gynecological cancer].
Saitoh S; Nakanishi A; Noda T; Yoh S; Ando Y; Moriyama I; Ichijo M
Gan No Rinsho; 1985 Jan; 31(1):65-72. PubMed ID: 3981803
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical demonstration of tumor antigen TA-4 in gynecologic tumors.
Ueda G; Inoue Y; Yamasaki M; Inoue M; Tanaka Y; Hiramatsu K; Saito J; Nishino T; Abe Y
Int J Gynecol Pathol; 1984; 3(3):291-8. PubMed ID: 6389386
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of assay of squamous cell carcinoma related antigen in tumors of the reproductive organs.
Takahashi K; Shirai T; Kijima S; Moriyama M; Shibukawa T; Iwanari O; Matsunaga I; Kitao M
Nihon Gan Chiryo Gakkai Shi; 1987 Aug; 22(7):1304-12. PubMed ID: 3430020
[No Abstract] [Full Text] [Related]
16. Carcinoembryonic antigen in malignant and nonmalignant gynecologic tumors: circulating levels and tissue localization.
Rutanen EM; Lindgren J; Sipponen P; Stenman UP; Saksela E; Seppäla M
Cancer; 1978 Aug; 42(2):581-90. PubMed ID: 354771
[No Abstract] [Full Text] [Related]
17. Relation of cell-mediated immunity in women with genital tract cancer to origin, histology, clinical stage and subsequent behaviour of neoplasm.
Khoo SK; Mackay EV
J Obstet Gynaecol Br Commonw; 1974 Mar; 81(3):229-35. PubMed ID: 4821482
[No Abstract] [Full Text] [Related]
18. [Studies on tumor-specific immune response evaluated by leucocyte migration inhibition test under agarose-plate in gynecological malignancy (author's transl)].
Nakamura S
Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):1015-24. PubMed ID: 6171133
[TBL] [Abstract][Full Text] [Related]
19. [The clinical significance of CA125 in patients with gynecological tumors--a comparative study on CA125 and other tumor markers].
Suzumori K; Yasui Y; Asai H; Hisaoka T; Mizuno K; Yagami Y
Gan No Rinsho; 1985 May; 31(5):544-8. PubMed ID: 3860666
[TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of specificity of serum CA125 as a tumor marker of ovarian carcinoma].
Iwasaka T; Ohkuma Y; Yoshimura T; Sugimori H
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):917-23. PubMed ID: 2426378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
